Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FTC Leaves Supplement Industry Still Waiting For Shift Away From RCT Standard For Claims

Jul 06 2016

• By Malcolm Spicer

Related Content

FTC Supplement Settlements Spotlight Bayer, Mark First Hoodia Action

Jan 08 2007

Regulatory News In Brief

Apr 22 2013

‘Wrong Type Of Expert’ Advised FTC On <em>Phillip’s Colon Health</em> Claims – CRN

Oct 07 2014

Related Companies

Bayer AG

Bayer AG

Nestle Health Science

Nestle Health Science

Additional Topics

United States Clinical Trials Business Strategies Advertising, Marketing & Sales Post Market Regulation & Studies Compliance Commercial Dietary Supplements Innovation Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.